logo
CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption
TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)
Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents
Elevated triglycerides and risk of myocardial infarction in HIV-positive persons
Tuberculosis among HIV-positive patients across Europe
Extended high viremics
Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries
The forgotten half of the equation
High clade C HIV-1 viremia
Testing and linkage of patients to early care
Measuring concurrent partnerships
Sustained viral response after only 6 weeks of peginterferon and ribavirin treatment for acute hepatitis C in a HIV-1-infected patient
Reducing tuberculosis-associated early mortality in antiretroviral treatment programmes in sub-Saharan Africa
Reducing tuberculosis-associated mortality among people with HIV
The global fight against HIV/AIDS